Potential mechanisms of disease progression and management of advanced-phase chronic myeloid leukemia
✍ Scribed by Jabbour, Elias J.; Hughes, Timothy P.; Cortés, Jorge E.; Kantarjian, Hagop M.; Hochhaus, Andreas
- Book ID
- 121282492
- Publisher
- Informa plc
- Year
- 2013
- Tongue
- English
- Weight
- 841 KB
- Volume
- 55
- Category
- Article
- ISSN
- 1042-8194
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Repetitive elements are heavily methylated in normal tissues, but hypomethylated in malignant tissues, driving the global genomic hypomethylation found in cancer. This hypomethylation results in chromosomal instability, a well-characterized feature of the advanced phases of chronic myeloid leukemia
## Abstract Although imatinib has been used as frontline therapy for chronic myeloid leukemia (CML) for nearly a decade, current debate is focused on the incorporation of newer tyrosine kinase inhibitors (TKIs) at diagnosis in light of recent US Food and Drug Administration approval of nilotinib an